Source comparison
Comparison Table: GHRH Analog Research Compounds
Sermorelin GHRH(1-29) ~20-30 min Pulsatile, physiological Aging GH axis; receptor sensitivity studies Link CJC-1295 (no DAC) GHRH(1-29) modified ~30 min to 2 hr Pulsatile, extended DPP-IV resistant studies; moderate duration CJC-1295 (DAC) GHRH(1-29)+DAC ~6-8
This comparison does not assign a generated winner or score.
- Sermorelin
- GHRH(1-29)
- ~20-30 min
- Pulsatile, physiological
- Aging GH axis; receptor sensitivity studies
- Link
- CJC-1295 (no DAC)
- GHRH(1-29) modified
- ~30 min to 2 hr
- Pulsatile, extended
- DPP-IV resistant studies; moderate duration
- CJC-1295 (DAC)
- GHRH(1-29)+DAC
- ~6-8 days
- Sustained
- Maximal GH elevation; body composition
- Tesamorelin
- GHRH(1-44) trans-3-hex
- ~25-38 min
- Pulsatile-sustained
- Visceral fat; GH pulse dynamics
- Ipamorelin (reference)
- Synthetic pentapeptide
- ~2 hr
- Pulsatile via GHSR
- GHRH-independent GH; synergy stack
- All compounds for research use only.